These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16369661)

  • 1. [Treatment of chronic hepatitis C and molecular biology tests].
    Córdoba Cortijo J; Molina Moreno JM
    Rev Esp Quimioter; 2005 Sep; 18(3):207-9. PubMed ID: 16369661
    [No Abstract]   [Full Text] [Related]  

  • 2. Clearance duration as a predictor of sustained viral response in patients with chronic hepatitis C virus genotype 1.
    Shenoy M; Levin J; Said A; Striker R
    J Infect Dis; 2005 Jun; 191(11):1993-5; 1995-6. PubMed ID: 15871137
    [No Abstract]   [Full Text] [Related]  

  • 3. How to use virological tools for optimal management of chronic hepatitis C.
    Chevaliez S; Pawlotsky JM
    Liver Int; 2009 Jan; 29 Suppl 1():9-14. PubMed ID: 19207960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus. Preface.
    Reddy KR; Kaplan DE
    Clin Liver Dis; 2008 Aug; 12(3):xiii-xiv. PubMed ID: 18625424
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure.
    Dai CY; Chuang WL; Huang JF; Hsieh MY; Yu ML
    Hepatology; 2008 Aug; 48(2):692-3; author reply 693-4. PubMed ID: 18666250
    [No Abstract]   [Full Text] [Related]  

  • 6. Ribavirin posology, observance, and sustained virologic response.
    Couzigou P; Foucher J; Castera L; De Ledinghen V
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):367. PubMed ID: 18063421
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid virologic response: a new milestone in the management of chronic hepatitis C.
    Poordad F; Reddy KR; Martin P
    Clin Infect Dis; 2008 Jan; 46(1):78-84. PubMed ID: 18171217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring response to antiviral treatment by serum hepatitis C virus core antigen: too early to take shortcuts?
    Mondelli MU
    J Hepatol; 2004 Mar; 40(3):536-8. PubMed ID: 15123372
    [No Abstract]   [Full Text] [Related]  

  • 9. HCV persistence: cure is still a four letter word.
    Feld JJ; Liang TJ
    Hepatology; 2005 Jan; 41(1):23-5. PubMed ID: 15690477
    [No Abstract]   [Full Text] [Related]  

  • 10. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C viral load decreases after cyclosporin treatment for erosive lichen planus.
    Franchi C; Frigerio E; Spadino S; Garutti C; Colombo DM; Altomare A; Altomare G
    Clin Exp Dermatol; 2009 Oct; 34(7):e254-5. PubMed ID: 19323656
    [No Abstract]   [Full Text] [Related]  

  • 12. Virological relapse in chronic hepatitis C.
    Poordad FF; Flamm SL
    Antivir Ther; 2009; 14(3):303-13. PubMed ID: 19474464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin in chronic hepatitis C: past and future.
    Loustaud-Ratti V; Rousseau A; Marquet P; Denis F; Alain S
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):249-53. PubMed ID: 19344238
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of patients infected with chronic hepatitis C genotype 2 and 3: more data, more questions?
    Graziadei IW; Vogel W
    Hepatology; 2009 Feb; 49(2):345-7. PubMed ID: 19177579
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recommendations for the treatment of chronic genotype 1 hepatitis C virus infection].
    Silva MO; Ridruejo E; Galdame O; Bessone F; Colombato L; Daruich J; Fainboim H; Fassio E; Fay F; Frider B; Gadano A; Galoppo MC; González J; Tanno H; Terg R; Villamil F; ;
    Acta Gastroenterol Latinoam; 2012 Sep; 42(3):234-49. PubMed ID: 23214356
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirin.
    Boo I; Fischer AE; Johnson D; Chin R; Giourouki M; Bharadwaj M; Bowden S; Torresi J; Drummer H
    J Clin Virol; 2007 Aug; 39(4):288-94. PubMed ID: 17569577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boceprevir.
    Maddur H; Kwo PY
    Hepatology; 2011 Dec; 54(6):2254-7. PubMed ID: 22095684
    [No Abstract]   [Full Text] [Related]  

  • 18. Modelling of viral dynamics in hepatitis B and hepatitis C clinical trials.
    Sypsa V; Hatzakis A
    Stat Med; 2008 Dec; 27(30):6505-21. PubMed ID: 18951370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association with 5'-untranslated region and response to interferon in chronic hepatitis C.
    Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
    Hepatogastroenterology; 2007; 54(75):854-7. PubMed ID: 17591078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chronic HCV positive hemodialysis patient with an unusual treatment complication.
    Mousa D; Altayeb A
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):282-6. PubMed ID: 17612040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.